These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


325 related items for PubMed ID: 32992102

  • 1. First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia.
    Tandon S, Shago M, Davidson S, Kanwar N, Fuligni F, Shlien A, Whitlock J, Villani A, Abla O.
    Cancer Genet; 2020 Oct; 248-249():31-33. PubMed ID: 32992102
    [Abstract] [Full Text] [Related]

  • 2. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
    Zerkalenkova E, Lebedeva S, Kazakova A, Tsaur G, Starichkova Y, Timofeeva N, Soldatkina O, Aprelova E, Popov A, Ponomareva N, Baidun L, Meyer C, Novichkova G, Maschan M, Maschan A, Marschalek R, Olshanskaya Y.
    Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
    [Abstract] [Full Text] [Related]

  • 3. Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis.
    Haddox CL, Mangaonkar AA, Chen D, Shi M, He R, Oliveira JL, Litzow MR, Al-Kali A, Hogan WJ, Elliott MA.
    Blood Cancer J; 2017 Sep 15; 7(9):e607. PubMed ID: 29016570
    [No Abstract] [Full Text] [Related]

  • 4. A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid Leukemia.
    Capela de Matos RR, Ney Garcia DR, Othman MAK, Moura Ferreira G, Melo JB, Carreira IM, Meyer C, Marschalek R, Costa ES, Land MGP, Liehr T, Ribeiro RC, Silva MLM.
    Cytogenet Genome Res; 2019 Sep 15; 157(4):213-219. PubMed ID: 30974445
    [Abstract] [Full Text] [Related]

  • 5. The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features.
    Ragusa D, Makarov EM, Britten O, Moralli D, Green CM, Tosi S.
    Cancer Rep (Hoboken); 2019 Oct 15; 2(5):e1207. PubMed ID: 32721124
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
    Xie W, Tang G, Wang E, Kim Y, Cloe A, Shen Q, Zhou Y, Garcia-Manero G, Loghavi S, Hu AY, Wang S, Bueso-Ramos CE, Kantarjian HM, Medeiros LJ, Hu S.
    Ann Hematol; 2020 Mar 15; 99(3):487-500. PubMed ID: 32006151
    [Abstract] [Full Text] [Related]

  • 10. KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.
    Yang N, Huh J, Chung WS, Cho MS, Ryu KH, Chung HS.
    Cancer Genet; 2015 Sep 15; 208(9):464-7. PubMed ID: 26164398
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inv(11)(q21q23); KMT2A-MAML2, a Recurrent Genetic Abnormality in T-Cell Therapy-related Acute Lymphoblastic Leukemia.
    Mariani RA, Silva M, Caparelli E, Jennings LJ, Yap KL, Leuer KM, Weinstein J, Gong S.
    J Pediatr Hematol Oncol; 2020 May 15; 42(4):e258-e261. PubMed ID: 31343482
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.